The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib Read More » September 29, 2022
The Oncology Institute Becomes Certified as a Patient Safety Organization Read More » September 12, 2022
